Eradication of hepatitis C virus with direct‐acting antivirals improves glycemic control in diabetes: A multicenter study

Autor: Hirokazu Takahashi, Takashi Nakahara, Tomomi Kogiso, Kento Imajo, Takaomi Kessoku, Takumi Kawaguchi, Tatsuya Ide, Miwa Kawanaka, Hideyuki Hyogo, Hideki Fujii, Masafumi Ono, Yoshihiro Kamada, Yoshio Sumida, Keizo Anzai, Masahito Shimizu, Takuji Torimura, Atsushi Nakajima, Katsutoshi Tokushige, Kazuaki Chayama, Yuichiro Eguchi, Japan Study Group of NAFLD (JSG‐NAFLD)

Publikováno v: JGH Open, Vol 5, Iss 2, Pp 228-234 (2021)

Abstract Background and Aim Hepatitis C virus (HCV) infection causes insulin resistance and diabetes as extrahepatic manifestations. We aimed to analyze the effect of HCV eradication by direct‐acting antiviral (DAA) agents on glucose tolerance. Met

Externí odkaz: https://doaj.org/article/86c8612a58f2493d99d7ffaf1431bd29

Surveillance of Hepatocellular Carcinoma in Nonalcoholic Fatty Liver Disease

Autor: Yoshio Sumida, Masashi Yoneda, Yuya Seko, Hiroshi Ishiba, Tasuku Hara, Hidenori Toyoda, Satoshi Yasuda, Takashi Kumada, Hideki Hayashi, Takashi Kobayashi, Kento Imajo, Masato Yoneda, Toshifumi Tada, Takumi Kawaguchi, Yuichiro Eguchi, Satoshi Oeda, Hirokazu Takahashi, Eiichi Tomita, Takeshi Okanoue, Atsushi Nakajima, Japan Study Group of NAFLD (JSG-NAFLD)

Publikováno v: Diagnostics, Vol 10, Iss 8, p 579 (2020)

Nonalcoholic fatty liver disease (NAFLD) is becoming the leading cause of hepatocellular carcinoma (HCC), liver-related mortality, and liver transplantation. There is sufficient epidemiological cohort data to recommend the surveillance of patients wi

Externí odkaz: https://doaj.org/article/cacd5946ed1a4f939a52b47ae3c89a75

Antidiabetic Therapy in the Treatment of Nonalcoholic Steatohepatitis

Autor: Yoshio, Sumida, Masashi, Yoneda, Katsutoshi, Tokushige, Miwa, Kawanaka, Hideki, Fujii, Masato, Yoneda, Kento, Imajo, Hirokazu, Takahashi, Yuichiro, Eguchi, Masafumi, Ono, Yuichi, Nozaki, Hideyuki, Hyogo, Masahiro, Koseki, Yuichi, Yoshida, Takumi, Kawaguchi, Yoshihiro, Kamada, Takeshi, Okanoue, Atsushi, Nakajima, Japan Study Group Of Nafld, Jsg-Nafld

Publikováno v: International Journal of Molecular Sciences
International Journal of Molecular Sciences, Vol 21, Iss 6, p 1907 (2020)

Liver-related diseases are the third-leading causes (9.3%) of mortality in type 2 diabetes (T2D) in Japan. T2D is closely associated with nonalcoholic fatty liver disease (NAFLD), which is the most prevalent chronic liver disease worldwide. Nonalcoho

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::27a3339133be28d799a2b0162e48d4a9
https://pubmed.ncbi.nlm.nih.gov/32168769

Insulin resistance correlated with the severity of liver histology in Japanese NAFLD patients: a multicenter retrospective study.

Autor: Kessoku, Takaomi, Yoneda, Masato, Sumida, Yoshio, Eguchi, Yuichiro, Fujii, Hideki, Hyogo, Hideyuki, Ono, Masafumi, Kawaguchi, Takumi, Nakajima, Atsushi, Japan Study Group of NAFLD (JSG-NAFLD), Japan Study Group of NAFLD

Publikováno v: Journal of Clinical Gastroenterology; Feb2015, Vol. 49 Issue 2, p169-170, 2p

FIB-4 First in the Diagnostic Algorithm of Metabolic-Dysfunction-Associated Fatty Liver Disease in the Era of the Global Metabodemic.

Autor: Sumida Y; Division of Hepatology and Pancreatology, Department of Internal Medicine, Aichi Medical University, Nagakute, Aichi 480-1195, Japan., Yoneda M; Division of Hepatology and Pancreatology, Department of Internal Medicine, Aichi Medical University, Nagakute, Aichi 480-1195, Japan., Tokushige K; Department of Internal Medicine, Institute of Gastroenterology, Tokyo Women's Medical University, Tokyo 162-8666, Japan., Kawanaka M; Department of General Internal Medicine2, Kawasaki Medical School, Okayama 700-8505, Japan., Fujii H; Department of Hepatology, Graduate School of Medicine, Osaka City University, Osaka 558-8585, Japan., Yoneda M; Department of Gastroenterology and Hepatology, Graduate School of Medicine, Yokohama City University, Yokohama 236-0004, Japan., Imajo K; Department of Gastroenterology and Hepatology, Graduate School of Medicine, Yokohama City University, Yokohama 236-0004, Japan., Takahashi H; Department of Metabolism and Endocrinology, Faculty of Medicine, Saga University, Saga 840-8502, Japan., Eguchi Y; Loco Medical General Institute, Saga 840-8502, Japan., Ono M; Division of Gastroenterology and Hepatology, Department of Internal Medicine, Tokyo Women's Medical University Medical Center East, Tokyo 116-8567, Japan., Nozaki Y; Department of Gastroenterology, National Center for Global Health and Medicine, Tokyo 162-8655, Japan., Hyogo H; Department of Gastroenterology, JA Hiroshima General Hospital, Hiroshima 738-8503, Japan., Koseki M; Division of Cardiovascular Medicine, Department of Medicine, Graduate School of Medicine, Osaka University, Suita, Osaka 565-0871, Japan., Yoshida Y; Department of Gastroenterology and Hepatology, Suita Municipal Hospital, Osaka 564-8567, Japan., Kawaguchi T; Division of Gastroenterology, Department of Medicine, Kurume University School of Medicine, Kurume 830-0011, Japan., Kamada Y; Department of Advanced Gastroenterology & Hepatology, Graduate School of Medicine, Osaka University, Suita, Osaka 565-0871, Japan., Okanoue T; Hepatology Center, Saiseikai Suita Hospital, Osaka 564-0013, Japan., Nakajima A; Department of Gastroenterology and Hepatology, Graduate School of Medicine, Yokohama City University, Yokohama 236-0004, Japan., Japan Study Group Of Nafld Jsg-Nafld; Japan Strategic Medical Administration Research Center (J-SMARC), Nagoya, Aichi 460-0011, Japan.

Publikováno v: Life (Basel, Switzerland) [Life (Basel)] 2021 Feb 14; Vol. 11 (2). Date of Electronic Publication: 2021 Feb 14.